Young adults diagnosed with type 2 diabetes early in life often face a more aggressive disease course than older adults. While metformin has long served as the standard first-line therapy, many clinicians are now reconsidering whether a “metformin-first and wait” strategy is enough for this higher-risk population. As research continues …
Read More »Can AI Eye Exams Expand Diabetic Retinopathy Screening Access?
Diabetic retinopathy remains one of the leading causes of preventable blindness worldwide. Yet despite clear screening guidelines, many patients with diabetes still miss their annual retinal exams. Busy schedules, limited specialist access, transportation barriers, and lack of awareness often delay diagnosis until vision changes become permanent. As healthcare systems search …
Read More »Cancer Therapy Is Changing Diabetes Management: What Clinicians Need to Know Now
Cancer treatment is evolving rapidly, and with that progress comes a new challenge for clinicians managing glucose disorders. As immune checkpoint inhibitors (ICIs) and PI3K inhibitors become more widely used in oncology, therapy-related hyperglycemia is appearing more often in clinical practice. Many patients receiving cancer treatment now face unexpected glucose …
Read More »Continuous Ketone Monitoring Is Coming Fast: Can It Actually Reduce Outpatient DKA Risk?
New advances in diabetes technology are moving beyond glucose alone. While continuous glucose monitoring transformed diabetes management over the last decade, wearable ketone monitoring systems are now emerging as the next major innovation. Researchers, device manufacturers, and international diabetes organizations are increasingly focused on whether real-time ketone data can help …
Read More »Continuous Ketone Monitoring in Hospital Care: Could It Improve DKA Management?
Diabetic ketoacidosis remains one of the most serious complications of diabetes, yet managing it often relies on intermittent data points. What if clinicians could see ketone levels change in real time instead of waiting hours between lab tests? Continuous ketone monitoring for DKA is now emerging as a promising concept …
Read More »When Diabetes Metrics Conflict: What to Do When A1C, CGM, and Symptoms Don’t Align
When diabetes metric discordance shows up in clinical practice, it can feel like trying to read three clocks that all tell different times. A1C suggests one story, continuous glucose monitoring points to another, and patient symptoms may not match either. So how should clinicians respond when these signals conflict? Understanding …
Read More »Continuous Ketone Monitoring in Practice: Who Should Use It and When?
Continuous ketone monitoring is gaining attention as a promising tool for detecting metabolic risk earlier than traditional methods. While glucose monitoring has long been the standard, ketones offer another layer of insight into how the body processes energy. Could this emerging technology reshape how clinicians assess risk and guide treatment …
Read More »Time in Range in 2026: Moving From Metric to Treatment Target
Continuous glucose monitoring has transformed diabetes care, but are we fully using the data it provides? In 2026, time in range is moving beyond a simple CGM metric and becoming a formal therapeutic target in diabetes care. While A1C remains important, time in range (TIR) offers a more dynamic and …
Read More »Diabetic Retinopathy in 2026: AI Screening and Early Detection Updates
In 2026, diabetic retinopathy screening is entering a new era driven by artificial intelligence, tele-retinal imaging, and smarter integration into primary care workflows. Despite improved glucose monitoring and widespread use of CGM systems, diabetic retinopathy remains a leading cause of preventable blindness in adults with diabetes. So how can clinicians …
Read More »Bringing CGM Into the Primary Care Visit: Practical Integration for Non-Specialists
Continuous glucose monitoring was once reserved for endocrinology clinics. Today, integrating CGM into primary care is essential as guidelines recommend earlier and broader use in both type 1 and type 2 diabetes. Yet many clinicians still feel unsure about how to interpret reports or fit CGM into a busy visit. …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.